Fig. 1From: Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safetyPRISMA flowchart summarizing the process to identify the eligible studies (Adapted from PRISMA 2020 flow diagram for new systematic reviews which included searches of databases and registers only [6])Back to article page